$4.71 Billion is the total value of Artal Group S.A.'s 106 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 35.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WW | Sell | WEIGHT WATCHERS INTL INC NEW | $2,104,730,000 | +12.2% | 20,818,300 | -29.3% | 44.73% | +90.5% |
| LXRX | Buy | LEXICON PHARMACEUTICALS INC | $722,891,000 | +44.7% | 60,240,864 | +3.4% | 15.36% | +145.8% |
| BAC | Buy | BANK AMER CORPcall | $179,007,000 | +37.2% | 6,350,000 | +46.0% | 3.80% | +133.0% |
| CELG | Buy | CELGENE CORPcall | $158,840,000 | +173.9% | 2,000,000 | +207.7% | 3.38% | +365.0% |
| BGNE | Buy | BEIGENE LTDsponsored adr | $103,768,000 | +2.9% | 675,000 | +12.5% | 2.20% | +74.9% |
| MS | New | MORGAN STANLEYcall | $71,100,000 | – | 1,500,000 | +100.0% | 1.51% | – |
| BMY | Buy | BRISTOL MYERS SQUIBB COcall | $69,175,000 | +21.5% | 1,250,000 | +38.9% | 1.47% | +106.5% |
| GS | Sell | GOLDMAN SACHS GROUP INCcall | $66,171,000 | -24.9% | 300,000 | -14.3% | 1.41% | +27.5% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $64,019,000 | -10.4% | 650,000 | +8.3% | 1.36% | +52.2% |
| GM | Sell | GENERAL MTRS COcall | $59,100,000 | -53.5% | 1,500,000 | -57.1% | 1.26% | -21.1% |
| WFC | Sell | WELLS FARGO CO NEWcall | $55,440,000 | -18.6% | 1,000,000 | -23.1% | 1.18% | +38.1% |
| IBB | New | ISHARES TRcall | $49,419,000 | – | 450,000 | +100.0% | 1.05% | – |
| XLRN | Buy | ACCELERON PHARMA INC | $48,520,000 | +46.0% | 1,000,000 | +17.6% | 1.03% | +147.8% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $45,298,000 | +20.5% | 2,900,000 | +16.0% | 0.96% | +104.5% |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $44,436,000 | +7.7% | 700,000 | +55.6% | 0.94% | +82.9% |
| NKTR | Buy | NEKTAR THERAPEUTICS | $43,947,000 | -40.9% | 900,000 | +28.6% | 0.93% | +0.3% |
| SRRK | New | SCHOLAR ROCK HLDG CORP | $37,378,000 | – | 2,396,040 | +100.0% | 0.79% | – |
| ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $36,750,000 | -24.6% | 1,000,000 | -20.0% | 0.78% | +28.0% |
| TSRO | Buy | TESARO INC | $35,576,000 | +3.8% | 800,000 | +33.3% | 0.76% | +76.2% |
| ARRY | ARRAY BIOPHARMA INC | $33,560,000 | +2.8% | 2,000,000 | 0.0% | 0.71% | +74.8% | |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $29,481,000 | -27.9% | 350,000 | -30.0% | 0.63% | +22.5% |
| BLUE | Buy | BLUEBIRD BIO INC | $26,682,000 | +4.2% | 170,000 | +13.3% | 0.57% | +76.6% |
| MDCO | MEDICINES COcall | $25,690,000 | +11.4% | 700,000 | 0.0% | 0.55% | +88.9% | |
| ZGNX | Buy | ZOGENIX INC | $22,100,000 | +175.9% | 500,000 | +150.0% | 0.47% | +370.0% |
| FATE | Buy | FATE THERAPEUTICS INC | $19,278,000 | +132.4% | 1,700,000 | +100.0% | 0.41% | +294.2% |
| BMRN | BIOMARIN PHARMACEUTICAL INCcall | $18,840,000 | +16.2% | 200,000 | 0.0% | 0.40% | +97.0% | |
| ALBO | Sell | ALBIREO PHARMA INC | $17,750,000 | -0.5% | 500,000 | -8.7% | 0.38% | +69.1% |
| FCX | FREEPORT-MCMORAN INCcall | $17,260,000 | -1.8% | 1,000,000 | 0.0% | 0.37% | +66.8% | |
| IFRX | Buy | INFLARX NV | $16,125,000 | +347.3% | 500,000 | +300.0% | 0.34% | +662.2% |
| SAGE | SAGE THERAPEUTICS INC | $15,653,000 | -2.8% | 100,000 | 0.0% | 0.33% | +64.9% | |
| FGEN | FIBROGEN INC | $15,650,000 | +35.5% | 250,000 | 0.0% | 0.33% | +129.7% | |
| TSRO | Buy | TESARO INCcall | $15,565,000 | +81.6% | 350,000 | +133.3% | 0.33% | +209.3% |
| XNCR | Buy | XENCOR INC | $14,804,000 | +64.6% | 400,000 | +33.3% | 0.32% | +178.8% |
| MDCO | Buy | MEDICINES CO | $14,680,000 | +122.8% | 400,000 | +100.0% | 0.31% | +280.5% |
| NKTR | Buy | NEKTAR THERAPEUTICScall | $14,649,000 | -31.1% | 300,000 | +50.0% | 0.31% | +16.9% |
| ANAB | Buy | ANAPTYSBIO INC | $14,208,000 | -28.2% | 200,000 | +5.3% | 0.30% | +22.3% |
| AUTL | New | AUTOLUS THERAPEUTICS PLCspon ads | $14,065,000 | – | 525,000 | +100.0% | 0.30% | – |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $13,985,000 | +166.1% | 50,000 | +11.1% | 0.30% | +350.0% |
| BPMC | Buy | BLUEPRINT MEDICINES CORPcall | $12,696,000 | +176.9% | 200,000 | +300.0% | 0.27% | +373.7% |
| ARGX | ARGENX SEsponsored adr | $12,429,000 | +3.0% | 150,000 | 0.0% | 0.26% | +74.8% | |
| ZFGN | ZAFGEN INC | $12,276,000 | +37.3% | 1,200,000 | 0.0% | 0.26% | +133.0% | |
| AXDX | ACCELERATE DIAGNOSTICS INC | $11,150,000 | -2.4% | 500,000 | 0.0% | 0.24% | +65.7% | |
| AXDX | New | ACCELERATE DIAGNOSTICS INCcall | $11,150,000 | – | 500,000 | +100.0% | 0.24% | – |
| PRQR | Sell | PROQR THRAPEUTICS N V | $10,950,000 | +87.4% | 1,500,000 | -21.1% | 0.23% | +219.2% |
| RGNX | Sell | REGENXBIO INC | $10,763,000 | +44.2% | 150,000 | -40.0% | 0.23% | +146.2% |
| EXEL | New | EXELIXIS INCcall | $10,760,000 | – | 500,000 | +100.0% | 0.23% | – |
| CBAY | Buy | CYMABAY THERAPEUTICS INC | $10,736,000 | +106.6% | 800,000 | +100.0% | 0.23% | +250.8% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INCcall | $9,849,000 | – | 100,000 | +100.0% | 0.21% | – |
| GBT | GLOBAL BLOOD THERAPEUTICS IN | $9,040,000 | -6.4% | 200,000 | 0.0% | 0.19% | +58.7% | |
| BOLD | Buy | AUDENTES THERAPEUTICS INC | $9,018,000 | +100.0% | 236,000 | +57.3% | 0.19% | +242.9% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $8,960,000 | +15.3% | 700,000 | +52.2% | 0.19% | +95.9% |
| SLDB | Buy | SOLID BIOSCIENCES INC | $8,908,000 | +691.8% | 250,000 | +66.7% | 0.19% | +1250.0% |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $7,852,000 | +67.5% | 400,000 | +60.0% | 0.17% | +183.1% |
| BLUE | New | BLUEBIRD BIO INCcall | $7,848,000 | – | 50,000 | +100.0% | 0.17% | – |
| FOLD | Sell | AMICUS THERAPEUTICS INCcall | $7,810,000 | -42.3% | 500,000 | -44.4% | 0.17% | -1.8% |
| DNLI | Buy | DENALI THERAPEUTICS INC | $7,625,000 | -13.9% | 500,000 | +11.1% | 0.16% | +45.9% |
| LJPC | Sell | LA JOLLA PHARMACEUTICAL CO | $7,293,000 | -18.4% | 250,000 | -16.7% | 0.16% | +38.4% |
| VTL | VITAL THERAPIES INC | $6,850,000 | +0.7% | 1,000,000 | 0.0% | 0.15% | +71.8% | |
| SELB | Buy | SELECTA BIOSCIENCES INC | $6,625,000 | +420.0% | 500,000 | +300.0% | 0.14% | +781.2% |
| ARPO | New | AERPIO PHARMACEUTICALS INC | $6,467,000 | – | 1,558,400 | +100.0% | 0.14% | – |
| STML | STEMLINE THERAPEUTICS INC | $6,420,000 | +4.9% | 400,000 | 0.0% | 0.14% | +76.6% | |
| TBIO | New | TRANSLATE BIO INC | $6,325,000 | – | 500,000 | +100.0% | 0.13% | – |
| AGEN | AGENUS INC | $6,243,000 | -51.8% | 2,750,000 | 0.0% | 0.13% | -17.9% | |
| ACIU | AC IMMUNE SA | $5,592,000 | -9.9% | 600,000 | 0.0% | 0.12% | +52.6% | |
| TGTX | Buy | TG THERAPEUTICS INC | $5,260,000 | +48.2% | 400,000 | +60.0% | 0.11% | +154.5% |
| DRNA | DICERNA PHARMACEUTICALS INC | $5,206,000 | +28.1% | 425,000 | 0.0% | 0.11% | +117.6% | |
| SPRO | SPERO THERAPEUTICS INC | $5,135,000 | +2.9% | 350,000 | 0.0% | 0.11% | +75.8% | |
| TORC | Buy | RESTORBIO INC | $5,033,000 | +16.7% | 550,000 | +22.2% | 0.11% | +98.1% |
| XLRN | New | ACCELERON PHARMA INCcall | $4,852,000 | – | 100,000 | +100.0% | 0.10% | – |
| AKBA | AKEBIA THERAPEUTICS INC | $4,741,000 | +4.7% | 475,000 | 0.0% | 0.10% | +77.2% | |
| CLVS | Sell | CLOVIS ONCOLOGY INCcall | $4,547,000 | -65.6% | 100,000 | -60.0% | 0.10% | -41.2% |
| AGIO | AGIOS PHARMACEUTICALS INCcall | $4,212,000 | +3.0% | 50,000 | 0.0% | 0.09% | +76.5% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $4,147,000 | +23.9% | 216,879 | 0.0% | 0.09% | +109.5% | |
| GLYC | Sell | GLYCOMIMETICS INC | $4,033,000 | -23.5% | 250,000 | -23.1% | 0.09% | +30.3% |
| SYBX | SYNLOGIC INC | $3,932,000 | +4.8% | 400,000 | 0.0% | 0.08% | +78.7% | |
| ADRO | ADURO BIOTECH INC | $3,850,000 | -24.7% | 550,000 | 0.0% | 0.08% | +28.1% | |
| WVE | Sell | WAVE LIFE SCIENCES LTD | $3,825,000 | -36.4% | 100,000 | -33.3% | 0.08% | +8.0% |
| DVAX | DYNAVAX TECHNOLOGIES CORPcall | $3,813,000 | -23.2% | 250,000 | 0.0% | 0.08% | +30.6% | |
| RCUS | ARCUS BIOSCIENCES INC | $3,672,000 | -20.7% | 300,000 | 0.0% | 0.08% | +34.5% | |
| IDRA | IDERA PHARMACEUTICALS INC | $3,630,000 | -28.3% | 2,750,000 | 0.0% | 0.08% | +22.2% | |
| AVRO | New | AVROBIO INC | $3,570,000 | – | 125,000 | +100.0% | 0.08% | – |
| MRNS | MARINUS PHARMACEUTICALS INC | $3,535,000 | +85.1% | 500,000 | 0.0% | 0.08% | +212.5% | |
| MGEN | MIRAGEN THERAPEUTICS INC | $3,205,000 | -8.6% | 500,000 | 0.0% | 0.07% | +54.5% | |
| TCDA | New | TRICIDA INC | $2,990,000 | – | 100,000 | +100.0% | 0.06% | – |
| UBX | New | UNITY BIOTECHNOLOGY INC | $3,012,000 | – | 200,000 | +100.0% | 0.06% | – |
| CRSP | Buy | CRISPR THERAPEUTICS AGnamen akt | $2,938,000 | +157.0% | 50,000 | +100.0% | 0.06% | +342.9% |
| SGMO | Buy | SANGAMO THERAPEUTICS INC | $2,840,000 | -0.4% | 200,000 | +33.3% | 0.06% | +66.7% |
| MGTA | New | MAGENTA THERAPEUTICS INC | $2,700,000 | – | 200,000 | +100.0% | 0.06% | – |
| CMTA | CLEMENTIA PHARMACEUTICALS IN | $2,632,000 | -13.1% | 200,000 | 0.0% | 0.06% | +47.4% | |
| NTLA | INTELLIA THERAPEUTICS INC | $2,462,000 | +29.7% | 90,000 | 0.0% | 0.05% | +116.7% | |
| CMRX | CHIMERIX INC | $2,380,000 | -8.5% | 500,000 | 0.0% | 0.05% | +54.5% | |
| KRYS | KRYSTAL BIOTECH INC | $2,231,000 | +47.4% | 150,000 | 0.0% | 0.05% | +147.4% | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $2,120,000 | -8.6% | 400,000 | 0.0% | 0.04% | +55.2% | |
| FIXX | HOMOLOGY MEDICINES INC | $2,040,000 | +9.1% | 100,000 | 0.0% | 0.04% | +87.0% | |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $1,735,000 | – | 100,000 | +100.0% | 0.04% | – |
| SNNAQ | New | SIENNA BIOPHARMACEUTICALS IN | $1,504,000 | – | 99,000 | +100.0% | 0.03% | – |
| XENE | XENON PHARMACEUTICALS INC | $1,380,000 | +87.8% | 150,000 | 0.0% | 0.03% | +222.2% | |
| NVLNF | NOVELION THERAPEUTICS INC | $944,000 | +5.2% | 256,400 | 0.0% | 0.02% | +81.8% | |
| TOCA | TOCAGEN INC | $934,000 | -21.2% | 100,000 | 0.0% | 0.02% | +33.3% | |
| TRILLIUM THERAPEUTICS INC | $900,000 | -16.7% | 150,000 | 0.0% | 0.02% | +35.7% | ||
| NVAX | NOVAVAX INC | $670,000 | -36.2% | 500,000 | 0.0% | 0.01% | +7.7% | |
| LIFE | ATYR PHARMA INC | $455,000 | -65.7% | 500,000 | 0.0% | 0.01% | -41.2% | |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $426,000 | -80.0% | 60,697 | -59.5% | 0.01% | -66.7% |
| OCX | ONCOCYTE CORPORATION | $383,000 | +21.6% | 150,000 | 0.0% | 0.01% | +100.0% | |
| EDIT | Exit | EDITAS MEDICINE INC | $0 | – | -25,000 | -100.0% | -0.01% | – |
| NERV | Exit | MINERVA NEUROSCIENCES INC | $0 | – | -300,000 | -100.0% | -0.02% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -100,000 | -100.0% | -0.02% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -750,000 | -100.0% | -0.04% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS INC | $0 | – | -100,000 | -100.0% | -0.04% | – |
| NG | Exit | NOVAGOLD RES INC | $0 | – | -1,000,000 | -100.0% | -0.05% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INCcall | $0 | – | -100,000 | -100.0% | -0.10% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -300,000 | -100.0% | -0.14% | – |
| IQ | Exit | IQIYI INCsponsored ads | $0 | – | -750,000 | -100.0% | -0.15% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -0.20% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INCcall | $0 | – | -150,000 | -100.0% | -0.21% | – |
| REGN | Exit | REGENERON PHARMACEUTICALScall | $0 | – | -50,000 | -100.0% | -0.22% | – |
| AVXS | Exit | AVEXIS INC | $0 | – | -160,000 | -100.0% | -0.25% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -300,000 | -100.0% | -0.31% | – |
| CAT | Exit | CATERPILLAR INC DELcall | $0 | – | -200,000 | -100.0% | -0.37% | – |
| XBI | Exit | SPDR SERIES TRUSTcall | $0 | – | -500,000 | -100.0% | -0.55% | – |
| INCY | Exit | INCYTE CORPcall | $0 | – | -550,000 | -100.0% | -0.57% | – |
| CVX | Exit | CHEVRON CORP NEWcall | $0 | – | -500,000 | -100.0% | -0.71% | – |
| XOM | Exit | EXXON MOBIL CORPcall | $0 | – | -1,000,000 | -100.0% | -0.93% | – |
| IBM | Exit | INTERNATIONAL BUSINESS MACHScall | $0 | – | -600,000 | -100.0% | -1.15% | – |
| SPY | Exit | SPDR S&P 500 ETF TRcall | $0 | – | -500,000 | -100.0% | -1.65% | – |
| BUFF | Exit | BLUE BUFFALO PET PRODS INC | $0 | – | -87,460,875 | -100.0% | -43.57% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.